GaudetDBlomDBruckertE, et al.Acute pancreatitis is highly prevalent and complications can be fatal in patients with familial chylomicronemia: Results from a survey of lipidologists. J Clin Lipidol2016; 10: 680–681.
2.
RabacchiCPisciottaLCefalùAB, et al.Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia. Atherosclerosis2015; 241: 79–86.
3.
KhavandiMVictoryJMyersonM. Prevalence of familial chylomicronemia syndrome (FCS): Are we underestimating?J Clin Lipidol2018; 12: 529–530.
BrunzellJDFamilial lipoprotein lipase deficiency. In: PagonRAAdamMPArdingerHH, et al.(eds). GeneReviews, Seattle, WA: University of Washington, Seattle, 2011, pp. 1993–2017.
6.
ShahNPChoLAhmedHM. Familial chylomicronemia syndrome: Clinical characteristics and long-term cardiovascular outcomes. J Am Coll Cardiol2018; 72: 1177–1179.
7.
MurphyMJShengXMacDonaldTM, et al.Hypertriglyceridemia and acute pancreatitis. JAMA Intern Med2013; 173: 162–164.
8.
FalkoJM. Familial chylomicronemia syndrome: A clinical guide for endocrinologists. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol2018; 24: 756–763.
9.
ChaudhryRViljoenAWierzbickiAS. Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome. Expert Rev Clin Pharmacol2018; 11: 589–598.
10.
WitztumJLGaudetDFreedmanSD, et al.Volanesorsen and triglyceride levels in familial chylomicronemia syndrome. N Engl J Med2019; 381: 531–542.